Searchable abstracts of presentations at key conferences in endocrinology

ea0014oc9.7 | Signal transduction | ECE2007

Seven transmembrane receptors mediated actin cytoskeleton rearrangement: comparison with constitutively active mutants of G protein alpha-subunits

Hrovat Alenka , Frangez Robert , Pogacnik Azra , Vrecl Milka

Reorganization of the actin cytoskeleton could coincide with the activation of several seven transmembrane receptors (7TM receptors) (1). Stimulation of Rho family members leads to rapid remodeling of the actin cytoskeleton and subsequent stress fiber formation and certain 7TM receptors were shown to induce Rho-dependent responses via heterotrimeric G-proteins. Gα12, Gα13 as well as Gαq/11 can link 7TM receptors to RhoA activatio...

ea0041ep484 | Diabetes complications | ECE2016

Association of the PPARG2 Pro12Ala, TNFα G(308)A and G(238)A, Lipc C(-514)T, Ace I/D, Slco1b1 Val174ala polymorphism with endothelial function and atorvastatin response in type 2 diabetic patients

Lebedeva Nadezhda , Vikulova Olga , Nikitin Alexei , Shamkhalova Minara , Shestakova Marina , II Dedov

Aim: To assess the association of the endothelial dysfunction (ED) parameters and the lipid-lowering response to atorvastatin therapy in patients with T2D with genetic markers of inflammation.Methods: We include 97 T2D patients with first prescribed atorvastatin 10–20 mg: M/F 26/71; mean age 57 years. After 12 month of statin therapy, patients had fasting lipid profiles and ED parameters repeated. For ED evaluation, we performed pulse wave analysis ...

ea0035p875 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

Pre-surgical medical treatment, a major prognostic factor of remission in acromegaly

Albarel Frederique , Castinetti Frederic , Morange Isabelle , Conte-Devolx Bernard , Guibert Nicolas , Dufour Henry , Brue Thierry

Context: Following the recent evolution in therapeutic strategies for GH-secreting pituitary adenomas, determining optimal individualized patient management is now crucial.Objective: To determine whether pre-surgical medical treatment (PSMT) in patients with acromegaly improves surgical outcome and to specify thresholds for such a strategy.Methods and design: This retrospective study included 110 newly diagnosed acromegalic patient...

ea0020p576 | Neuroendocrinology, Pituitary and Behaviour | ECE2009

Initial and long-term outcome of surgery in acromegaly: a ten-year, single centre study in 115 patients

Albarel Frederique , Castinetti Frederic , Morange Isabelle , Dubois Noemie , Dufour Henry , Conte-Devolx Bernard , Brue Thierry

Objective: To analyze characteristics of patients who had surgery for a GH-secreting adenoma in the past decade in our centre, to evaluate their initial outcome and long-term recurrence rate using stringent criteria and identify potential predictive factors of surgical remission.Methods: This retrospective study included 115 consecutive patients with acromegaly operated at the neurosurgical department of the Timone Hospital Marseille between 1997 and 200...

ea0016p372 | Growth factors | ECE2008

Acromegaly is associated with high plasma fibrinogen and C reactive protein values after normalization of growth hormone and IGF-1

Friedrich Nele , Nonnenberg Dennis , Spilcke-Liss Elisabeth , Volzke Henry , Dorr Marcus , Wallaschofski Henri

Background: Acromegaly is associated with increased morbidity and mortality from cardiovascular disease. Several studies indicate that reduction of growth hormone (GH) to <1 μg/l or normalization of serum IGF-I reduces mortality to expected levels. Inflammatory markers, such as C-reactive protein (CRP) or haemostatic markers, such as fibrinogen have emerged as important cardiovascular risk markers in the general population.Objective and design: ...

ea0070ep542 | Hot topics (including COVID-19) | ECE2020

COVID-19 infection in a patient with life-treatening hypercalcaemia and sickle cell disease

Seguna Desiree , Marshall Henry , Barroso Filipa , Parvanta Laila , Adams Ashok , Berney Daniel , Akker Scott , Cavlan Dominic

A 21-year-old woman with homozygous sickle cell disease, presented to A&E with vomiting and diarrhoea, and was noted to be hypercalcaemic (corrected calcium 3.00 mmol/l [ref. 2.2–2.6]; phosphate 0.48 mmol/l [ref. 0.8–1.5]). She reported polyuria and polydipsia, but no other symptoms of hypercalcaemia. There was no history of renal stones, renal impairment, or fragility fracture. A maternal aunt required parathyroidectomy in middle age. Bloods revealed PTH 138.4 pmo...

ea0031oc3.3 | Reproduction, growth and development | SFEBES2013

Regulation of G protein-coupling specificity via cis and trans activation of the LH/chorionic gonadotrophin receptor (LHCGR)

Jonas Kim , Muller Adolfo Rivero , Chou Yen Yin , Ji Tae , Hanyaloglu Aylin

Accepted dogma once stated that G protein-coupled receptors (GPCRs) function as monomers, however, over the last decade in vitro experiments have shown GPCRs to function as dimers and higher order oligomers. We have recently reported the first in vivo evidence for the physiological importance of Class A GPCR homodimerisation using the LHCGR as a model receptor. Transgenic co-expression of binding deficient LHCGR (LHCGR-LH) and signalling deficient ...

ea0041gp149 | Pituitary - Clinical | ECE2016

Impact of AIP and Gαi-2 proteins on clinical features of sporadic GH-secreting pituitary adenomas

Ritvonen Elina , Pitkanen Esa , Karppinen Atte , Vehkavaara Satu , Demir Hande , Paetau Anders , Schalin-Jantti Camilla , Karhu Auli

Introduction: In sporadic acromegaly, downregulation of AIP protein of the adenomas associates with invasive tumour features and reduced response to somatostatin analogue treatment. AIP is a regulator of Gαi signaling, but it is not known how the biological function of the Gαi pathway is controlled.Aim: To study somatic GNAS and AIP mutation status, AIP and Gαi-2 protein expressions, Ki67 proliferation indices, and clinical parameters in p...

ea0038p4 | Bone | SFEBES2015

Mutations in G-protein subunit αq (GNAQ) are not a cause of familial hypocalciuric hypercalcaemia

Modi Manish , Cranston Treena , Rogers Angela , Howles Sarah , Gorvin Caroline , Thakker Rajesh

Familial hypocalciuric hypercalcaemia (FHH) is an autosomal dominant disorder characterised by hypercalcaemia and inappropriately low renal calcium excretion. FHH can be classified into three types: FHH1, caused by calcium-sensing receptor (CaSR) loss-of-function mutations, accounting for >65% of cases; FHH2, due to loss-of-function mutations of the G-protein α11 subunit (Gα11); and FHH3, resulting from loss-of-function mutations in the adap...

ea0050ecp1.1 | (1) | SFEBES2017

Insights into G-protein coupled receptor (GPCR) trafficking and biased signalling by studies of calcium homeostasis

Gorvin Caroline

G-protein coupled receptors (GPCR) mediate the effects of multiple hormones, and consequently are fundamental for endocrine functions including glucose homeostasis, thyroid function, fertility, control of urine output, and bone remodelling. Mutations in genes encoding GPCRs result in endocrine disorders, and studies of these mutations has improved understanding of GPCR signalling and trafficking pathways, and could facilitate novel therapies. The calcium-sensing receptor (CaSR...